{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T22:33:19Z","timestamp":1721082799708},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.contraception.2014.09.001","type":"journal-article","created":{"date-parts":[[2014,9,15]],"date-time":"2014-09-15T18:48:52Z","timestamp":1410806932000},"page":"19-24","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["What happens when we routinely give doxycycline to medical abortion patients?"],"prefix":"10.1016","volume":"91","author":[{"given":"Laura J.","family":"Frye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Chong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverly","family":"Winikoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.contraception.2014.09.001_bb0005","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.contraception.2009.03.010","article-title":"Effectiveness of medical abortion with mifepristone and buccal misoprostol through 59 gestational days","volume":"80","author":"Fjerstad","year":"2009","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.contraception.2014.09.001_bb0010","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.contraception.2012.06.011","article-title":"First-trimester medical abortion with mifepristone 200mg and misoprostol: a systematic review","volume":"87","author":"Raymond","year":"2013","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.contraception.2014.09.001_bb0015","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijgo.2009.02.007","article-title":"Acceptability and feasibility of medical abortion in Nepal","volume":"106","author":"Karki","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"10.1016\/j.contraception.2014.09.001_bb0020","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.contraception.2006.10.008","article-title":"Predictors of acceptability of medication abortion","volume":"75","author":"Teal","year":"2007","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.contraception.2014.09.001_bb0025","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.contraception.2009.04.012","article-title":"Efficacy, acceptability and safety of medication abortion in low-income, urban Latina women","volume":"80","author":"Teal","year":"2009","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.contraception.2014.09.001_bb0030","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0002-9378(97)70511-8","article-title":"Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion","volume":"176","author":"Winikoff","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2014.09.001_bb0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1742-4755-8-19","article-title":"Client preferences and acceptability for medical abortion and MVA as early pregnancy termination method in northwest Ethiopia","volume":"8","author":"Woldetsadik","year":"2011","journal-title":"Reprod Health"},{"issue":"3","key":"10.1016\/j.contraception.2014.09.001_bb0040","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.contraception.2005.03.011","article-title":"Safety of mifepristone abortions in clinical use","volume":"72","author":"Henderson","year":"2005","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.contraception.2014.09.001_bb0045","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.contraception.2006.03.016","article-title":"Mifepristone and misoprostol sequential regimen side effects, complications and safety","volume":"74","author":"Sitruk-Ware","year":"2006","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.contraception.2014.09.001_bb0050","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.contraception.2004.04.009","article-title":"Infection after medical abortion: a review of the literature","volume":"70","author":"Shannon","year":"2004","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.contraception.2014.09.001_bb0055","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa0809146","article-title":"Rates of serious infection after changes in regimens for medical abortion","volume":"361","author":"Fjerstad","year":"2009","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.contraception.2014.09.001_bb0060","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1056\/NEJMoa051620","article-title":"Fatal toxic shock syndrome associated with Clostridium sordellii after medical abortion","volume":"353","author":"Fischer","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2014.09.001_bb0065","series-title":"Mifepristone US postmarketing adverse events summary through 04\/30\/2011","author":"USFDA","year":"2013"},{"issue":"11","key":"10.1016\/j.contraception.2014.09.001_bb0070","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1086\/344464","article-title":"Toxic shock syndrome due to Clostridium sordellii: a dramatic postpartum and postabortion disease","volume":"35","author":"Sinave","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.contraception.2014.09.001_bb0075","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.contraception.2013.11.020","article-title":"Reduction in infection-related mortality since modifications in the regimen of medical abortion","volume":"89","author":"Trussell","year":"2014","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.contraception.2014.09.001_bb0080","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/AOG.0b013e3182755763","article-title":"Significant adverse events and outcomes after medical abortion","volume":"121","author":"Cleland","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.contraception.2014.09.001_bb0085","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/01.AOG.0000444454.67279.7d","article-title":"ACOG Practice Bulletin No. 143: Medical management of first-trimester abortion","volume":"123","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.contraception.2014.09.001_bb0090","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1479-828X.2012.01460.x","article-title":"Antibiotic prophylaxis in obstetric and gynaecological procedures: a review","volume":"52","author":"Clifford","year":"2012","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"4","key":"10.1016\/j.contraception.2014.09.001_bb0095","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.contraception.2010.11.006","article-title":"Prevention of infection after induced abortion: release date October 2010: SFP guideline 20102","volume":"83","author":"Achilles","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2014.09.001_bb0100","series-title":"2014 Clinical Policy Guidelines","author":"National Abortion Federation","year":"2014"},{"key":"10.1016\/j.contraception.2014.09.001_bb0105","series-title":"Safe abortion: technical and policy guidance for health systems","author":"World Health Organization","year":"2012"},{"issue":"2","key":"10.1016\/j.contraception.2014.09.001_bb0110","first-page":"91","article-title":"Providing mifepristone-misoprostol medical abortion: the view from the clinic","volume":"54","author":"Ellertson","year":"1999","journal-title":"J Am Med Wom Assoc"},{"issue":"4","key":"10.1016\/j.contraception.2014.09.001_bb0115","first-page":"871","article-title":"ACOG Practice Bulletin No.67: Clinical management guidelines of obstetrician-gynecologists: medical management of abortion","volume":"106","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.contraception.2014.09.001_bb0120","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.contraception.2010.08.022","article-title":"Severity of infection following the introduction of new infection control measures for medical abortion","volume":"83","author":"Fjerstad","year":"2011","journal-title":"Contraception"},{"issue":"9","key":"10.1016\/j.contraception.2014.09.001_bb0125","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.clinthera.2005.09.005","article-title":"Safety of doxycycline and minocycline: a systematic review","volume":"27","author":"Smith","year":"2005","journal-title":"Clin Ther"},{"issue":"10","key":"10.1016\/j.contraception.2014.09.001_bb0130","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1001\/archderm.1997.03890460044005","article-title":"Comparative safety of tetracycline, minocycline, and doxycycline","volume":"133","author":"Shapiro","year":"1997","journal-title":"Arch Dermatol"},{"issue":"11","key":"10.1016\/j.contraception.2014.09.001_bb0135","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1097\/00007611-199411000-00006","article-title":"Compliance with doxycycline therapy for outpatient treatment of pelvic inflammatory disease","volume":"87","author":"Brookoff","year":"1994","journal-title":"South Med J"},{"issue":"6","key":"10.1016\/j.contraception.2014.09.001_bb0140","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/00007435-199211000-00011","article-title":"Compliance with antibiotic therapy for Chlamydia trachomatis and Neisseria gonorrhoeae","volume":"19","author":"Katz","year":"1992","journal-title":"Sex Transm Dis"},{"issue":"5","key":"10.1016\/j.contraception.2014.09.001_bb0145","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/00007435-199905000-00006","article-title":"Measured versus self-reported compliance with doxycycline therapy for chlamydia-associated syndromes: high therapeutic success rates despite poor compliance","volume":"26","author":"Bachmann","year":"1999","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.contraception.2014.09.001_bb0150","series-title":"Antimicrobial resistance: global report on surveillance","author":"World Health Organization","year":"2014"},{"issue":"5","key":"10.1016\/j.contraception.2014.09.001_bb0155","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/AOG.0b013e31826c315f","article-title":"Extending outpatient medical abortion services through 70days of gestational age","volume":"120","author":"Winikoff","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.contraception.2014.09.001_bb0160","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.contraception.2005.05.017","article-title":"Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56days of last menstrual period","volume":"72","author":"Middleton","year":"2005","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.contraception.2014.09.001_bb0165","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/AOG.0b013e31818d8eb4","article-title":"Two distinct oral routes of misoprostol in mifepristone medical abortion: a randomized controlled trial","volume":"112","author":"Winikoff","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2014.09.001_bb0170","series-title":"Concordance, adherence and compliance in medicine taking","author":"Horne","year":"2005"},{"issue":"6","key":"10.1016\/j.contraception.2014.09.001_bb0175","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1200\/JCO.1993.11.6.1189","article-title":"Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring","volume":"11","author":"Waterhouse","year":"1993","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.contraception.2014.09.001_bb0180","doi-asserted-by":"crossref","first-page":"e649","DOI":"10.1542\/peds.2005-2551","article-title":"Changing their minds with time: a comparison of hypothetical and actual reproductive behaviors in parents of children with cystic fibrosis","volume":"118","author":"Sawyer","year":"2006","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.contraception.2014.09.001_bb0185","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0029-7844(03)00041-3","article-title":"A randomized clinical trial of prophylaxis for vacuum abortion: 3 versus 7 days of doxycycline","volume":"101","author":"Lichtenberg","year":"2003","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.contraception.2014.09.001_bb0190","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0002-9378(88)90787-9","article-title":"Prophylactic antibiotics for suction curettage abortion: Results of a clinical controlled trial","volume":"158","author":"Levallois","year":"1998","journal-title":"Am J Obstet Gynecol"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782414006519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782414006519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T11:53:19Z","timestamp":1598269999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782414006519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0010782414006519"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2014.09.001","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What happens when we routinely give doxycycline to medical abortion patients?","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2014.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}